Agency
Health & Hospital Corporation
Health & Hospital Corporation was paid $2.19M by Medicaid between Jan 2018 and Nov 2024, across 73 billing codes. Its largest line is 90472, Immunization administration, each additional vaccine (list separately) — 23% of everything it billed.
33Billing provider infoHEALTH & HOSPITAL CORPORATION
INDIANAPOLIS, IN 46205
INDIANAPOLIS, IN 46205
33aNPI1639273840assigned 09/08/2006
33bProvider typePublic Health or Welfare Agency
28Total paid$2.19M
24GClaims165,596
24DCodes billed73
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Public Health or Welfare Agency providers in Indiana
Rank by total paid#3 of 53
Median peer was paid$64K
This provider vs. median34×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 19,562 | $167K | |
| 2019 | 37,404 | $287K | |
| 2020 | 14,829 | $188K | |
| 2021 | 15,845 | $225K | |
| 2022 | 22,522 | $320K | |
| 2023 | 25,717 | $433K | |
| 2024incomplete | 29,717 | $572K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 90472 | Immunization administration, each additional vaccine (list separately) | 23% | 21,931 | 18,237 | $512K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 15% | 30,174 | 25,232 | $332K |
| 90716 | 10.0% | 5,328 | 4,651 | $219K | |
| 90651 | 8.8% | 8,316 | 7,271 | $194K | |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 8.7% | 2,914 | 2,567 | $191K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 7.8% | 2,804 | 2,531 | $172K |
| 90715 | 2.8% | 7,760 | 6,804 | $61K | |
| 83655 | 2.6% | 7,753 | 6,222 | $57K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 2.6% | 1,914 | 1,724 | $56K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 2.5% | 1,914 | 1,723 | $56K |
| 86703 | 1.6% | 3,380 | 3,078 | $35K | |
| 90713 | 1.5% | 3,951 | 3,598 | $32K |
61 more codes
| 90707 | 1.4% | 1,392 | $30K | |
| 90739 | 1.4% | 323 | $30K | |
| 90620 | <1% | 2,948 | $20K | |
| 81025 | <1% | 2,858 | $19K | |
| 90686 | <1% | 5,973 | $19K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 211 | $18K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 529 | $15K |
| 36415 | Collection of venous blood by venipuncture | <1% | 4,020 | $14K |
| 86580 | <1% | 3,319 | $14K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 159 | $13K |
| 81000 | <1% | 3,561 | $11K | |
| 90746 | <1% | 434 | $11K | |
| 90734 | <1% | 5,628 | $8K | |
| 90674 | <1% | 1,289 | $6K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 32 | $6K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 50 | $4K |
| 90480 | <1% | 752 | $4K | |
| 99383 | <1% | 40 | $4K | |
| T1029 | Comprehensive environmental lead investigation, not including laboratory analysis, per dwelling | <1% | 34 | $4K |
| 86480 | <1% | 2,615 | $3K | |
| 36416 | <1% | 1,701 | $3K | |
| 99382 | <1% | 29 | $3K | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 70 | $3K |
| 99173 | <1% | 1,387 | $2K | |
| 90661 | <1% | 854 | $2K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 142 | $2K |
| 90670 | <1% | 2,573 | $2K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 78 | $1K |
| 96150 | <1% | 127 | $1K | |
| 87210 | <1% | 284 | $877.57 | |
| 92551 | <1% | 117 | $832.00 | |
| 90677 | <1% | 139 | $780.00 | |
| 90710 | <1% | 2,654 | $640.12 | |
| 81003 | <1% | 269 | $485.38 | |
| 90619 | <1% | 1,762 | $435.00 | |
| 87428 | <1% | 13 | $424.00 | |
| 90473 | <1% | 29 | $403.98 | |
| 90694 | <1% | 17 | $300.00 | |
| 90632 | <1% | 18 | $270.00 | |
| 86592 | <1% | 39 | $125.46 | |
| D1206 | Topical application of fluoride varnish | <1% | 26 | $89.00 |
| 90682 | <1% | 3,156 | $80.01 | |
| 90633 | <1% | 7,816 | $75.33 | |
| D0150 | Comprehensive oral evaluation - new or established patient | <1% | 13 | $71.00 |
| 90744 | <1% | 1,477 | $50.04 | |
| 90656 | <1% | 68 | $39.86 | |
| 90696 | <1% | 754 | $7.76 | |
| 90698 | <1% | 238 | $0.03 | |
| 90700 | <1% | 1,039 | $0.02 | |
| 90647 | <1% | 847 | $0.01 | |
| 90685 | <1% | 32 | $0.01 | |
| 90697 | 0% | 115 | $0.00 | |
| 90723 | 0% | 656 | $0.00 | |
| 86481 | 0% | 14 | $0.00 | |
| 86682 | 0% | 1,300 | $0.00 | |
| 90671 | 0% | 146 | $0.00 | |
| 91322 | 0% | 674 | $0.00 | |
| 91321 | 0% | 545 | $0.00 | |
| 91300 | 0% | 12 | $0.00 | |
| D1120 | Dental cleaning, child | 0% | 12 | $0.00 |
| 90672 | 0% | 48 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGUTWEIN, MATTHEW (PRESIDENT AND CEO)
Parent organizationHEALTH & HOSPITAL CORPORATION
| Provider | Location | Paid |
|---|---|---|
| Health & Hospital Corporation | Indianapolis, IN | $510K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.